Local Inventor Honored for Developing World s First Antihistamine
George Rieveschl, PhD, while a chemical engineering professor at the University of Cincinnati (UC), invented the drug Benadryl, the worlds first effective antihistamine.
Dr. Rieveschl will be recognized in conjunction with the 60th anniversary of Benadryl, commonly used to treat allergy symptoms such as hay fever, rashes and hives. The reception will be held from 5:30 to 7 p.m. at the Queen City Club,
Dr. Rieveschl found that his two-part compound, originally tested to improve muscle-relaxing medications, dramatically blocked histamine, a chemical released in the body that narrows air passages in the lungs and causes inflammation.
This surprising breakthrough led to Benadryl becoming the first FDA-approved prescription antihistamine in 1946. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer, Inc.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970. He currently is a professor emeritus of environmental engineering.
Jane Henney, MD, senior vice president and provost for health affairs at the UC Academic Health Center, and Karen Gould, PhD, dean of the
Invented by UC scientist George Rieverschl, PhD, Benadryl is the world's first effective antihistamine.
Tags
Related Stories
University of Cincinnati Cancer Center names David Gius, MD, PhD, as director
February 10, 2026
Following a highly competitive national search, the University of Cincinnati Cancer Center has appointed David Gius, MD, PhD, as its next director.
Breakthrough UC study sheds light on survival of new neurons in adult brain
February 9, 2026
Research from the University of Cincinnati College of Medicine, recently published in the journal Nature Communications, is revealing how immune cells in the adult brain regulate the generation of new neurons.
Powerful AI can help diagnose substance use disorder
February 5, 2026
A new study by the University of Cincinnati uses a novel artificial intelligence to predict substance use disorder-defining behaviors with up to 83% accuracy.